HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Revlon Licensing Revenue Leads North American Q3 Sales Gain

This article was originally published in The Rose Sheet

Executive Summary

Revlon's North American sales increased 1.5% to $232 mil. in the third quarter, driven by approximately $10 mil. in licensing revenue, as well as sales growth in the hair color and color cosmetics businesses, the company reported during its 1Q3 presentation Oct. 31

You may also be interested in...



Revlon Boosted Marketing, Product Cuts To Follow $150 Mil. Investment

Revlon plans to accelerate several elements of its growth strategy using $150 mil. in cash from a funding proposal by investment firm MacAndrews & Forbes, which is wholly-owned by Revlon's majority investor, Chairman Ronald Perelman, the company announced Dec. 18

Revlon Boosted Marketing, Product Cuts To Follow $150 Mil. Investment

Revlon plans to accelerate several elements of its growth strategy using $150 mil. in cash from a funding proposal by investment firm MacAndrews & Forbes, which is wholly-owned by Revlon's majority investor, Chairman Ronald Perelman, the company announced Dec. 18

Sally Hansen Color Cosmetics Bring Healing Positioning To Category

Del Labs is making a full-scale push into the color cosmetics category in January with the launch of Sally Hansen Healing Beauty, a makeup line with a "good-for-you" positioning, Exec VP-Marketing William McMenemy said

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010729

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel